This filing is informational and reflects ongoing efforts to expand clinical adoption of the SynCardia Total Artificial Heart. Traders should monitor future commercial metrics such as implant volume, revenue trends, or new center adoption for signs of progress, but no immediate financial impact is expected from this announcement.
Price Chart
Executive Summary
Picard Medical, Inc. announced its participation in the inaugural 'Hands-On Training Day' at the Technology and Heart Failure Therapeutics 2026 conference in Boston on March 1, 2026. The event will feature interactive clinical training on the SynCardia Total Artificial Heart, led by company clinical specialists, as part of its commercial expansion and clinician education strategy.
Key Facts
- Picard Medical will participate in the 'Hands-On Training Day' at the THT 2026 conference on March 1, 2026, in Boston.
- The training is an interactive, case-based program focused on real-world application of the SynCardia Total Artificial Heart for advanced heart failure patients.
- Senior Clinical Specialists Lauren Wallace and Skyler Peffly will lead the session, offering hands-on experience with the Companion 2 Driver, Freedom Portable Driver, and the SynCardia Total Artificial Heart.
- The company states this event supports its commercial expansion strategy and aims to strengthen clinical partnerships and global adoption.
- No financial data, guidance updates, or material business developments were disclosed.
Financial Impact
No direct financial impact disclosed; event supports long-term commercial and educational outreach.
Risk Factors
- No financial or operational data was provided, limiting near-term trading relevance.
- Investor sentiment may be influenced by perceived momentum in clinical adoption, but this remains speculative without supporting metrics.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001829126-26-001652 |
| Document: picardmedical_ex99-1.htm | 0001829126-26-001652 |
| Document: 0001829126-26-001652-index-headers.html | 0001829126-26-001652 |
| Document: 0001829126-26-001652-index.html | 0001829126-26-001652 |
| Document: 0001829126-26-001652.txt | 0001829126-26-001652 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $7.09 | awaiting T+60 | — | $6.85 (−3.39%) |
Oct 22, 2026 4d ago | S-3 | $7.37 | awaiting T+60 | — | $6.85 (+7.06%) |
Oct 6, 2026 20d ago | 8-K | $8.74 | awaiting T+60 | — | $6.85 (+21.62%) |
Jul 27, 2026 13w ago | 8-K | $0.0878 $0.2096 | ▲ +138.72% | ▲ +134.67% | $6.85 (+7701.82%) |
Jul 15, 2026 14w ago | DEFA14A | $0.1600 $0.1896 | ▲ +18.50% | ▲ +14.79% | $6.85 (+4181.25%) |
Jul 8, 2026 15w ago | DEFA14A | $0.1500 $0.0864 | ▼ −42.40% | ▼ −44.89% | $6.85 (+4466.67%) |
Jul 2, 2026 16w ago | 8-K / 425 | $0.1694 | awaiting T+60 | — | $6.85 (+3943.68%) |
Jun 29, 2026 17w ago | 8-K | $0.1559 $0.0910 | ▼ −41.63% | ▼ −45.25% | $6.85 (+4293.84%) |
Jun 2, 2026 21w ago | Press Release | $13.50 | awaiting T+60 | — | $6.85 (−49.26%) |
Jun 2, 2026 21w ago | 8-K | $13.50 | awaiting T+60 | — | $6.85 (+49.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers